Kooman & Associates
- SEC CIK
- 0001961850
- Latest filing
- Jul 22, 2026
GSK holding history
GSK plc in every 13F filed by Kooman & Associates, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GSK overviewAll 13F holders of GSKFull Q2 2026 holdings
- Shares (Q2 2026)
- 5,692
- Value
- $298.4K
- % of portfolio
- 0.1%
- Quarters held
- 14
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 5,692 | $298.4K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 5,692 | $314.1K | 0.1% | −1,562−21.5% | Reduced | Holders |
| Q4 2025 | 7,254 | $355.7K | 0.1% | −561−7.2% | Reduced | Holders |
| Q3 2025 | 7,815 | $337.3K | 0.1% | −19−0.2% | Reduced | Holders |
| Q2 2025 | 7,834 | $300.8K | 0.1% | +2,142+37.6% | Added | Holders |
| Q1 2025 | 5,692 | $220.5K | 0.1% | +5,692 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −6,229−100.0% | Sold out | Holders |
| Q3 2024 | 6,229 | $254.6K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 6,229 | $239.8K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 6,229 | $267.0K | 0.1% | −40−0.6% | Reduced | Holders |
| Q4 2023 | 6,269 | $232.3K | 0.1% | +40+0.6% | Added | Holders |
| Q3 2023 | 6,229 | $225.8K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 6,229 | $222.0K | 0.1% | −47−0.7% | Reduced | Holders |
| Q1 2023 | 6,276 | $223.3K | 0.1% | +582+10.2% | Added | Holders |
| Q4 2022 | 5,694 | $200.1K | 0.2% | – | No prior filing | Holders |